Edwards Lifesciences (EW) Short-Term Debt repayments (2010 - 2013)

Edwards Lifesciences has reported Short-Term Debt repayments for 4 years, with the latest figure at $67.8 million in Q3 2013.

• For the quarter ending Q3 2013, Short-Term Debt repayments rose 59.15% year-over-year to $67.8 million; the trailing twelve-month figure through Sep 2013 stood at $515.7 million (up 100.97% YoY), and the FY2012 full-year result was $367.5 million, down 12.85% from the prior year.
• Short-Term Debt repayments for Q3 2013 stood at $67.8 million, down from $133.7 million in the prior quarter.
• The five-year high for Short-Term Debt repayments was $305.4 million in Q3 2011, with the low at $5.2 million in Q1 2011.
• Average Short-Term Debt repayments over 4 years is $96.8 million, with a median of $67.8 million recorded in 2013.
• Year-over-year, Short-Term Debt repayments tumbled 91.93% in 2011 and soared 2217.31% in 2012.
• Tracing EW's Short-Term Debt repayments over 4 years: stood at $95.2 million in 2010, then slumped by 52.73% to $45.0 million in 2011, then surged by 246.44% to $155.9 million in 2012, then tumbled by 56.51% to $67.8 million in 2013.
• The last three Short-Term Debt repayments figures came in at $67.8 million (Q3 2013), $133.7 million (Q2 2013), and $158.3 million (Q1 2013), per Business Quant data.

Peer Comparison